See why we’re the #1 CGM in the US*.
Find out what features make FreeStyle Libre systems an easy choice. Compare CGMs below to find a sensor that fits your lifestyle.
The FreeStyle Libre systems are designed with you in mind.
Proven to be accurate2,3 with strong, reliable connectivity2
Easy to wear comfortably4,†5–6 for up to 15 days
Updated readings every minute‡
5x faster than other CGMs7
FreeStyle Libre systems vs.
Features |
Dexcom G7 System |
||
|---|---|---|---|
|
Glucose reading frequency |
Every minute2 |
Every minute3 |
Every 5 minutes8 |
|
Sensor size |
Smaller than two stacked pennies9 |
Same thickness as two stacked quarters9 |
1.5x thicker than the FreeStyle Libre 3 system9 |
|
Overpatch needed |
No |
No |
Yes8 |
|
Alarms/alerts |
Yes, real-time alarms§ (based on readings every 1 minute) |
Yes, real-time alarms§ (based on readings every 1 minute) |
Yes, real-time alarms (based on readings every 5 minutes)8 |
|
Application |
No overpatch required—easy to apply4 using a one-piece applicator |
No overpatch required—easy to apply†5–6 |
Requires the use of an overpatch8 |
|
App |
Libre app|| |
Libre app|| |
Dexcom G7 CGM app |
|
Sensor lifespan |
15 days |
15 days |
10 days + 12-hour grace period8 |
|
Sensor memory storage |
15 days2 |
8 hours3 |
24 hours8 |
|
MBPA or IBOA skin allergens |
No¶9 |
No¶9 |
Evidence shows IBOA was found in Dexcom G79,10 |
|
Pump compatibility |
Yes2 |
Yes3 |
Yes8 |
IBOA = isobornyl acrylate; MBPA = methylenebisphosphonic acid
“The FreeStyle Libre 3 system has liberated me. I am excited about life!”
- Shirley, FreeStyle Libre 3 system user
The views expressed should not be used for medical diagnosis or treatment or as a substitute for professional medical advice. Individual symptoms, situations and circumstances may vary.
Readings you can trust and share#**
- Easily see your glucose levels, where they’re going, and where they’ve been.
- Automatically# uploads glucose data to a secure cloud-based system** accessible to you and caregivers††‡‡
Costs about a dollar a day§§9
FreeStyle Libre systems are priced 60% lower than other CGM systems||||9, helping you access the most affordable¶¶9 CGM available.
Need support? MyFreeStyle is here for you.
Exclusive for FreeStyle Libre systems users! The MyFreeStyle program gives you access to free tips and tools by email or text you can use to make informed decisions.
Join today and you’ll get:
Easy tutorials for applying, starting, checking, and interpreting sensor readings on your smartphone||
Meal and activity tips
Insights into how food and exercise affect glucose levels
Advice for measuring progress so you can celebrate your wins
Some people may even qualify for a free sensor♢.
Need help?
Contact customer support, available 7 days a week, from 8AM to 8PM Eastern Time, excluding holidays.
Contact us
Learn more about the apps||.
The FreeStyle Libre family of apps allow you to access your glucose data and receive real-time glucose alarms||.
Discover the apps
The FreeStyle Libre 2 system includes the Libre 2 Plus sensor, Libre 2 sensor, Libre 2 app, Libre app, and the Libre 2 reader.
The FreeStyle Libre 3 system includes the Libre 3 Plus sensor, Libre 3 sensor, Libre 3 app, Libre app, and the Libre 3 reader.
FreeStyle Libre 3 and FreeStyle Libre 2 systems are indicated for use in people with diabetes ages 4 and older.
FreeStyle Libre 2 Plus sensor and 3 Plus sensor are indicated for use in people with diabetes age 2 and older.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
* Based on retail and durable medical equipment (DME) sales data for patient’s last-filled prescription, by manufacturer.
† Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
‡ 60-minute warm-up required when starting the sensor.
§ Alarm notifications will only be received when alarms settings are enabled and turned on and sensor is within 20 feet (FreeStyle Libre 2) or 33 feet (FreeStyle Libre 3) unobstructed of the reading device.
|| The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
¶ Not made with these skin allergens. IBOA and MBPA not detected. Test method limit of detection was 0.0016 μg per device for IBOA and 0.0079 μg per device for MBPA.
# The user’s device must have internet connectivity for glucose data to automatically upload to LibreView.
** The FreeStyle Libre systems apps are designed to facilitate data sharing between patients and their healthcare providers and caregivers.
†† The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
‡‡ Check the support section of www.librelinkup.com for information about mobile device and operating system compatibility. LibreLinkUp is not intended to be used for dosing decisions or to replace self-monitoring practices as advised by a physician and requires registration with LibreView.
§§ Based on prescription claims for commercially insured patients using the FreeStyle Libre personal CGM systems. Does not include Medicare, Medicaid, uninsured, and other federal or state healthcare program patients. The actual amount a patient pays may vary. The FreeStyle Libre personal CGM systems require a prescription.
|||| Based on a comparison of list prices of the FreeStyle Libre personal CGM systems versus competitors’ prescription CGM systems, assuming annual use of one receiver (or equivalent hardware) and quantity of transmitters and/or sensors according to use life. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
¶¶ Based on prescription claims for commercially insured or uninsured patients starting on the FreeStyle Libre personal CGM systems compared to competitor CGMs. Does not include Medicare, Medicaid, and other federal or state healthcare program patients. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
♢ Eligible patients will receive one (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor for users with a compatible mobile phone operating system at $0 copay. The expiration date of the voucher is 60 days from the issue date. This program is available for patients with Type 1 diabetes or Type 2 diabetes or gestational diabetes. Patients ages 18 and older are eligible to sign up and receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor. Patients ages 2–17 are eligible to receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor through their parent or guardian. This offer is void where prohibited by law. Abbott may modify or rescind this offer at any time without notice. The discounts are not available to beneficiaries of Kaiser Permanente, Medicare, Medicaid or other federal or state healthcare programs, residents of Massachusetts, or US territories (other than Puerto Rico). The free (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor is provided as a sample and is limited to one sample per eligible person per product identification number. The FreeStyle Libre 2 Plus sensor or FreeStyle Libre 3 Plus sensor cannot be re-sold, traded nor submitted to any third-party payer for reimbursement and is not provided as any inducement for future purchases. The free sample card is not health insurance.
References: 1. Fokkert, Marion, et al. "Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4)." BMJ Open Diabetes Research and Care 7, no. 1 (2019): e000809. https://doi.org/10.1136/bmjdrc-2019-000809. 2. FreeStyle Libre 3 User's Manual. 3. FreeStyle Libre 2 User’s Manual. 4. Alva, Shridhara, et al. "Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System with Improved Sensor Design." Journal of Diabetes Science and Technology (2025): 19322968251329364. https://doi.org/10.1177/19322968251329364. 5. Haak, Thomas, et al. "Flash Glucose-sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (2017): 55–73. https://doi.org/10.1007/s13300-016-0223-6. 6. Campbell, Fiona M., et al. "Outcomes of Using Flash Glucose Monitoring Technology by Children and Young People With Type 1 Diabetes in a Single Arm Study." Pediatric Diabetes 19, no. 7 (2018): 1294–1301. https://doi.org/10.1111/pedi.12735. 7. Based on FreeStyle Libre 2 and FreeStyle Libre 3 User Manuals, Dexcom G7 CGM User Guide, and Medtronic Guardian Connect System User Guide. 8. Dexcom G7 CGM User Guide. 9. Data on file. Abbott Diabetes Care, Inc. 10. Mowitz, Martin, et al. “New Device, ‘Old’ Allergens. Allergic Contact Dermatitis Caused by the Dexcom G7 Glucose Sensor.” Contact Dermatitis 90, no. 5 (2024): 495–500. https://doi.org/10.1111/cod.14514.
ADC-36559 v6.0